We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002064:SZSEHuafon Chemical Co.,Ltd Analysis

Data as of 2026-05-21 - not real-time

CN¥10.37

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Huafon Chemical is trading at CNY 10.37, just above the computed support of CNY 10.23 and well below the resistance near CNY 12.15. The 20‑day SMA (≈11.22) sits above the current price, while the 200‑day SMA (≈10.02) is below, indicating a bullish long‑term bias, yet the MACD histogram is negative and the signal line is bearish, suggesting short‑term momentum weakness. The RSI of 39 points to a mildly oversold condition, and the 30‑day volatility of roughly 41% combined with an ultra‑low computed beta signals that price swings can be sharp despite low market correlation.
Fundamentally, the company posted CNY 24.65 bn of revenue with 7.2% YoY growth, maintaining a gross margin of 14.5% and an operating margin of 13.0%. Cash generation is robust (operating cash flow > CNY 4.1 bn) and the balance sheet is strong with a debt‑to‑equity of 6.3 and a cash‑to‑debt ratio exceeding 5. The DCF‑derived fair value of CNY 10.73 implies roughly 24% upside, while the forward PE of 12.96 and a dividend yield of 1.87% (payout 50%) enhance the value case. These metrics together suggest the stock is currently undervalued, offering both growth potential and income appeal, but investors should remain mindful of the near‑term technical weakness and sector‑specific regulatory exposure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above support with bearish MACD
  • RSI indicating near‑oversold condition
  • Stable trading volume limiting downside risk

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair‑value gap suggesting ~24% upside
  • Revenue growth of 7.2% and improving forward PE
  • Sustainable dividend yield with 50% payout ratio

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified spandex product portfolio meeting long‑term demand
  • Strong cash generation and low leverage
  • Moderate sector risk balanced by consistent dividend and growth prospects

Key Metrics & Analysis

Financial Health

Revenue Growth7.20%
Profit Margin8.20%
P/E Ratio25.9
ROE7.40%
ROA3.96%
Debt/Equity6.33
P/B Ratio1.8
Op. Cash FlowCN¥4.1B
Free Cash FlowCN¥2.6B

Technical Analysis

TrendBullish
RSI39.1
SupportCN¥10.23
ResistanceCN¥12.15
MA 20CN¥11.22
MA 50CN¥10.86
MA 200CN¥10.02
MACDBearish
VolumeStable
Fear & Greed Index90.29

Valuation

Fair ValueCN¥10.73
Target PriceCN¥12.89
Upside/Downside24.25%
GradeUndervalued
TypeBlend
Dividend Yield1.87%

Risk Assessment

Beta0.01
Volatility40.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.